Literature DB >> 23376867

Prevalence of stimulant use in a sample of US medical students.

Jadon R Webb1, Mark A Valasek, Carol S North.   

Abstract

BACKGROUND: Stimulant use for academic performance is widespread among college students, but less is known about use among students obtaining advanced degrees.
METHODS: In this cross-sectional survey, we measured the prevalence and demographic correlates of prescription stimulant use among a sample of US medical students.
RESULTS: The lifetime prevalence of stimulant use in this sample of 144 medical students was 20%, and prevalence of use during medical school was 15%. More white students (32%) than Asian students (7%) had used stimulants. Nine percent of respondents reported an attention-deficit/hyperactivity disorder (ADHD) diagnosis, and those diagnosed were more than 30 times more likely to have used stimulants compared with those without a diagnosis. Of those who had taken stimulants, 83% reported using them specifically for cognitive performance enhancement such as studying better and staying awake longer while on clinical duties.
CONCLUSIONS: This study suggests a high prevalence of stimulant use among medical students compared with the general population. Personal experience with these medications as medical students could impact physician attitudes and prescribing patterns toward patients seeking help for ADHD-related symptoms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23376867

Source DB:  PubMed          Journal:  Ann Clin Psychiatry        ISSN: 1040-1237            Impact factor:   1.567


  12 in total

1.  Methylphenidate use among medical students at Ben-Gurion University of the Negev.

Authors:  Yael Givon Cohen; Renana Wilkof Segev; Nurit Shlafman; Victor Novack; Gal Ifergane
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

2.  Life context of pharmacological academic performance enhancement among university students--a qualitative approach.

Authors:  Elisabeth Hildt; Klaus Lieb; Andreas Günter Franke
Journal:  BMC Med Ethics       Date:  2014-03-07       Impact factor: 2.652

3.  Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.

Authors:  Andreas G Franke; Carolin Papenburg; Elena Schotten; Peter B Reiner; Klaus Lieb
Journal:  BMC Fam Pract       Date:  2014-01-08       Impact factor: 2.497

Review 4.  Attention-deficit/hyperactivity disorder in postsecondary students.

Authors:  Kevin Nugent; Wallace Smart
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-26       Impact factor: 2.570

5.  Pharmacological Neuroenhancement: teachers' knowledge and attitudes-Results from a survey study among teachers in Germany.

Authors:  Andreas G Franke; Sophie Lehmberg; Michael Soyka
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-09-20

6.  Prevalence and correlates of non-medical stimulants and related drug use in a sample of South African undergraduate medical students.

Authors:  Mari Retief; Chris Verster
Journal:  S Afr J Psychiatr       Date:  2016-06-24       Impact factor: 1.550

Review 7.  The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.

Authors:  Barbara J Sahakian; Annette B Bruhl; Jennifer Cook; Clare Killikelly; George Savulich; Thomas Piercy; Sepehr Hafizi; Jesus Perez; Emilio Fernandez-Egea; John Suckling; Peter B Jones
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

8.  Pharmacological Neuroenhancement in the Field of Economics-Poll Results from an Online Survey.

Authors:  Pavel Dietz; Michael Soyka; Andreas G Franke
Journal:  Front Psychol       Date:  2016-04-19

Review 9.  The Role of Adenosine Receptors in Psychostimulant Addiction.

Authors:  Inmaculada Ballesteros-Yáñez; Carlos A Castillo; Stefania Merighi; Stefania Gessi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

10.  Pharmacological neuroenhancement and the ability to recover from stress - a representative cross-sectional survey among the German population.

Authors:  Christiana Bagusat; Angela Kunzler; Jennifer Schlecht; Andreas G Franke; Andrea Chmitorz; Klaus Lieb
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.